v3.24.1.1.u2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net loss $ (7,106) $ (5,791)
Adjustments to reconcile net loss income to net cash used in operating activities:    
Stock-based compensation 985 804
Depreciation 0 1
Fair value change in derivative liabilities 0 0
Unrealized loss from short-term investments 10 27
Change in assets and liabilities:    
Accounts receivable (998) (1,536)
Contract assets and unbilled receivables 213 1,085
Prepaid expenses and other assets (461) 365
Accounts payable (89) 1,152
Accrued expenses 1,730 247
Net cash used in operating activities (5,716) (3,646)
Investing activities    
Net cash used in investing activities 0 0
Financing activities    
Proceeds from issuance of common stock in connection with the at-the-market program and purchase agreement 2,479 0
Issuance costs (61) 0
Share repurchases for the payment of employee taxes (42) 0
Net cash provided by financing activities 2,376 0
Net decrease in cash and cash equivalents (3,340) (3,646)
Cash and cash equivalents at beginning of period 50,501 42,634
Cash and cash equivalents at end of period 47,161 38,988
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 0 0
Cash paid for interest 0 0
Supplemental non-cash financing transactions:    
Unpaid issuance costs $ 104 $ 2

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL